A single chorionic gonadotropin assay for maternal serum screening for Down's syndrome

Area of Science:

• Biochemistry
• Genetics
• Obstetrics

Background:

• Down syndrome (trisomy 21) is a genetic disorder.
• Prenatal screening is crucial for early detection.
• Accurate and accessible screening methods are needed.

Purpose of the Study:

• To develop a simple enzyme immunoassay for human chorionic gonadotropin (hCG).
• To evaluate its utility as a prenatal screening test for Down syndrome.
• To assess detection rates and feasibility in clinical practice.

Main Methods:

• Developed a straightforward enzyme immunoassay for maternal serum hCG.
• Conducted retrospective analysis on pregnancies with trisomy 21.
• Performed a prospective study on 9040 pregnant women under 38 years.

Main Results:

• The assay measures human chorionic gonadotropin (hCG) in undiluted maternal serum.
• Retrospective analysis indicated a two-thirds detection rate for trisomy 21 with a 5% amniocentesis rate.
• Prospective study confirmed the assay's usefulness in a large cohort.

Conclusions:

• The developed enzyme immunoassay is a valuable tool for prenatal Down syndrome screening.
• It offers a practical approach for detecting trisomy 21.
• The assay demonstrates effectiveness in a large-scale prospective evaluation.